Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Powder essential fatty acid supplement (0913212)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
KeyOmega oral powder 4g sachets
0913212A0BBAAAA
|
KeyOmega powder essential fatty acid supplement | Powder essential fatty acid supplement (0913212) | Nutrition and Blood | 263 |
|
DocOmega oral powder 4g sachets
0913212A0BCAAAB
|
DocOmega powder essential fatty acid supplement | Powder essential fatty acid supplement (0913212) | Nutrition and Blood | 61 |
|
Generic DocOmega oral powder 4g sachets
0913212A0AAABAB
|
Powder essential fatty acid supplement (0913212) | Powder essential fatty acid supplement (0913212) | Nutrition and Blood | No data available |
|
Generic KeyOmega oral powder 4g sachets
0913212A0AAAAAA
|
Powder essential fatty acid supplement (0913212) | Powder essential fatty acid supplement (0913212) | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.